These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17709468)

  • 61. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD
    Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
    [TBL] [Abstract][Full Text] [Related]  

  • 62. UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease.
    Gregg K; Hakki M; Kaul DR
    Transpl Infect Dis; 2014 Apr; 16(2):320-3. PubMed ID: 24621186
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.
    Choi SH; Hwang JY; Park KS; Kim Y; Lee SH; Yoo KH; Kang ES; Ahn JH; Sung KW; Koo HH; Kim YJ
    Transpl Infect Dis; 2014 Dec; 16(6):919-29. PubMed ID: 25405808
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing.
    Chou S; Ercolani RJ; Sahoo MK; Lefterova MI; Strasfeld LM; Pinsky BA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4697-702. PubMed ID: 24890586
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
    Cihlar T; Fuller MD; Cherrington JM
    J Virol; 1998 Jul; 72(7):5927-36. PubMed ID: 9621055
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antiviral drug resistance of human cytomegalovirus.
    Lurain NS; Chou S
    Clin Microbiol Rev; 2010 Oct; 23(4):689-712. PubMed ID: 20930070
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
    Jabs DA; Martin BK; Forman MS; Dunn JP; Davis JL; Weinberg DV; Biron KK; Baldanti F;
    J Infect Dis; 2001 Jan; 183(2):333-337. PubMed ID: 11120934
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene.
    Martin M; Goyette N; Boivin G
    J Clin Virol; 2010 Dec; 49(4):296-8. PubMed ID: 20843736
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The biology of cytomegalovirus drug resistance.
    Hakki M; Chou S
    Curr Opin Infect Dis; 2011 Dec; 24(6):605-11. PubMed ID: 22001948
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of SYBR Green I-based real-time PCR assay for detection of drug resistance mutations in cytomegalovirus.
    Liu JB; Zhang Z
    J Virol Methods; 2008 Apr; 149(1):129-35. PubMed ID: 18280587
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Analysis of ganciclovir-resistant cytomegalovirus].
    Eizuru Y
    Nihon Rinsho; 1998 Jan; 56(1):151-5. PubMed ID: 9465681
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rapid simultaneous detection by real-time PCR of cytomegalovirus UL97 mutations in codons 460 and 520 conferring ganciclovir resistance.
    Göhring K; Mikeler E; Jahn G; Hamprecht K
    J Clin Microbiol; 2006 Dec; 44(12):4541-4. PubMed ID: 17035493
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure.
    Gilbert C; Boivin G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4860-6. PubMed ID: 16304146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain.
    Hamprecht K; Eckle T; Prix L; Faul C; Einsele H; Jahn G
    J Infect Dis; 2003 Jan; 187(1):139-43. PubMed ID: 12508158
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection.
    Mihm J; Leyking S; Dirks J; Smola S; Fliser D; Sester U; Sester M; Wilkens H; Rissland J
    J Clin Virol; 2016 Sep; 82():5-8. PubMed ID: 27389910
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ganciclovir and maribavir susceptibility phenotypes of cytomegalovirus UL97 ATP binding region mutations detected by expanded genotypic testing.
    Chou S; Watters M; Sinha R; Kleiboeker S
    Antiviral Res; 2021 Sep; 193():105139. PubMed ID: 34273445
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir.
    Boutolleau D; Burrel S; Agut H
    Antiviral Res; 2011 Jul; 91(1):32-5. PubMed ID: 21570426
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Opposite effects of cytomegalovirus UL54 exonuclease domain mutations on acyclovir and cidofovir susceptibility.
    Chou S
    Antiviral Res; 2021 Nov; 195():105181. PubMed ID: 34560144
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.
    Chou S
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2371-8. PubMed ID: 20385869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.